AlphaFold predicted structure
DLG3 · Q92796

Mean pLDDT
73.8/ 100
Confident
817 residues
Confidence breakdown
- Very high(≥ 90)48%
- Confident(70–90)20%
- Low(50–70)3%
- Very low(< 50)29%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
discs large MAGUK scaffold protein 3
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesIntellectual disability
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesFetal anomalies
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesCAKUT
Unexplained kidney failure in young people
Unexplained young onset end-stage renal disease - additional genes
UnknownX-linked non-syndromic intellectual disability
hereditary disease
non-syndromic X-linked intellectual disability
Intellectual disability
X-linked intellectual disability, Siderius type
neurodegenerative disease
neurodevelopmental disorder
epilepsy
breast cancer
breast carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
MAGUK p55 subfamily member 3
Participates in cell spreading through the phosphoinositide-3-kinase (PI3K) pathway by connecting CADM1 to DLG1 and the regulatory subunit of phosphoinositide-3-kinase (PI3K) (PubMed:24503895). Stabilizes HTR2C at the plasma membrane and prevents its desensitization. May participates in the maintenance of adherens junctions (By similarity)
DLG3 · Q92796

Mean pLDDT
73.8/ 100
Confident
817 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0